Department of Pediatrics Wayne State University, in affiliation with Children's Hospital of Michigan, Detroit, MI, USA.
Pediatr Crit Care Med. 2011 Jul;12(4):422-5. doi: 10.1097/PCC.0b013e3181fe3010.
To describe the safety and use of flexible bronchoscopy in the management of respiratory complications in patients on extracorporeal membrane oxygenation for cardiac failure.
Retrospective cohort study.
Pediatric intensive care unit at a tertiary care university hospital.
Patients requiring extracorporeal membrane oxygenation for cardiac failure in the pediatric intensive care unit between 2003 and 2008.
None.
Forty-eight patients required extracorporeal membrane oxygenation for cardiac failure (32 after surgery for congenital heart disease, 16 for acquired heart disease) during the study period. Seven patients (15%) underwent 17 flexible bronchoscopies. Median age and weight at extracorporeal membrane oxygenation cannulation was 10 days (range, 4 days to 27 yrs) and 3.2 kg (range, 2.8-66 kg), respectively. Median duration of extracorporeal membrane oxygenation in this group was longer than those not undergoing flexible bronchoscopy (314 vs. 114 hrs, p < .001). In all cases, flexible bronchoscopy indication was persistent atelectasis despite conventional ventilator adjustments. Activated clotting time during flexible bronchoscopy was maintained between 180 and 220 secs (normal, 80-150 secs) in all patients. No major complications occurred. A minor complication occurred in one of 17 flexible bronchoscopies (6%), scant oozing that stopped with epinephrine lavage. Findings included bronchus compression or narrowing in four patients and mucous plugging in three patients. Bronchoalveolar lavage specimens identified new ventilator-associated infections in three patients. In two patients with mucous plugging, serial bronchoscopies were accompanied by stepwise decreases in extracorporeal membrane oxygenation flow, thereby facilitating discontinuation from extracorporeal membrane oxygenation support.
In patients requiring extracorporeal membrane oxygenation for cardiac failure, flexible bronchoscopy can be performed safely, provide important diagnostic information to the bedside clinician, and, perhaps, therapeutic benefit to the patient.
描述在体外膜肺氧合治疗心力衰竭患者的呼吸并发症管理中使用可弯曲支气管镜的安全性和效果。
回顾性队列研究。
三级儿童医院重症监护病房。
2003 年至 2008 年期间在儿科重症监护病房因心力衰竭需要体外膜肺氧合的患者。
无。
在研究期间,48 例患者因心力衰竭需要体外膜肺氧合(先天性心脏病术后 32 例,获得性心脏病术后 16 例)。7 例(15%)患者进行了 17 次可弯曲支气管镜检查。体外膜肺氧合插管时的中位年龄和体重分别为 10 天(范围,4 天至 27 岁)和 3.2 公斤(范围,2.8-66 公斤)。该组体外膜肺氧合的中位时间长于未行可弯曲支气管镜检查的患者(314 小时比 114 小时,p <.001)。在所有情况下,可弯曲支气管镜检查的指征均为常规呼吸机调整后持续肺不张。在所有患者中,可弯曲支气管镜检查期间的激活凝血时间均维持在 180-220 秒之间(正常范围为 80-150 秒)。无重大并发症发生。17 次可弯曲支气管镜检查中有 1 例(6%)发生轻微并发症,即微量渗血,用肾上腺素灌洗后停止。发现 4 例患者存在支气管压迫或狭窄,3 例患者存在黏液栓。支气管肺泡灌洗液标本在 3 例患者中发现了新的呼吸机相关感染。在 2 例黏液栓患者中,连续支气管镜检查伴随着体外膜肺氧合流量的逐步下降,从而有助于停止体外膜肺氧合支持。
在因心力衰竭需要体外膜肺氧合的患者中,可弯曲支气管镜检查可安全进行,为床边临床医生提供重要的诊断信息,并可能为患者带来治疗益处。